drugset / Trial / NCT00452556
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to see if sequence inversion of Intensity - modulated Radiotherapy (IMRT) for prostate cancer, can improve the safety and deliverability of concurrent docetaxel chemotherapy with long - term hormonal therapy. The hypothesis is that inverting the traditional sequence of radiotherapy can delay the time to treatment - induced bowel toxicity.
Timeline
- Start
- 2007-05
- Primary completion
- 2017-02
- Completion
- 2017-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 20 mg/m2 | — |
| Background | Leuprolide | Other / unclassified | — | — |